Among these genes, we focused on CA9, because previous studies have shown that CA9 promotes tumor cell migration and invasion in vitro by inhibiting the RHOA pathway, and is highly expressed in younger patients with cervical and hepatocellular malignancies [15, 16]. Here, RHOA is linked to neoplasm.